The leading region of plasmids is a hotspot for many anti-defence systems, encoding anti-CRISPR, anti-restriction and other counter-defence proteins; focusing on this region could lead to the ...
In mid-2023, the SWOG S1826 phase 3 trial in advanced Hodgkin lymphoma reported highly positive primary results earlier than expected, after the trial’s second planned interim analysis found the ...